Adjuvantation of an Influenza Hemagglutinin Antigen with TLR4 and NOD2 Agonists Encapsulated in Poly(D,L-Lactide-Co-Glycolide) Nanoparticles Enhances Immunogenicity and Protection against Lethal Influenza Virus Infection in Mice.

将流感血凝素抗原与 TLR4 和 NOD2 激动剂佐剂结合，封装在聚（D,L-乳酸-共-乙醇酸）纳米颗粒中，可增强免疫原性，并提高小鼠对致命性流感病毒感染的保护作用